Turnstone Biologics Corp. (TSBX)
Aug 11, 2025 - TSBX was delisted (reason: acquired by XOMA)
0.3550
0.00 (0.00%)
Inactive · Last trade price on Aug 8, 2025
Turnstone Biologics Employees
Turnstone Biologics had 14 employees as of December 31, 2024. The number of employees decreased by 66 or -82.50% compared to the previous year.
Employees
14
Change (1Y)
-66
Growth (1Y)
-82.50%
Revenue / Employee
n/a
Profits / Employee
-$3,371,429
Market Cap
8.21M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14 | -66 | -82.50% |
Dec 31, 2023 | 80 | -28 | -25.93% |
Dec 31, 2022 | 108 | - | - |
TSBX News
- 3 months ago - Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights - GlobeNewsWire
- 4 months ago - Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 10 months ago - Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewsWire
- 1 year ago - Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study - Benzinga
- 1 year ago - Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 1 year ago - Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer - GlobeNewsWire
- 1 year ago - Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 1 year ago - Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference - GlobeNewsWire